GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.4000
+0.0206 (5.43%)
At close: Nov 26, 2025, 4:00 PM EST
0.3998
-0.0002 (-0.05%)
After-hours: Nov 26, 2025, 7:45 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $11.88 million as of November 26, 2025. Its market cap has decreased by -55.61% in one year.
Market Cap
11.88M
Enterprise Value
6.87M
1-Year Change
-55.61%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $11.88M, an increase of 1,038.16%. That is a compound annual growth rate of 45.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 11.88M | -49.02% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |